Bharat Immunologicals Net Income vs. Debt to Equity

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 22.20  0.95  4.47%

The Drivers Module shows relationships between Bharat Immunologicals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bharat Immunologicals Biologicals Corp Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities

Bharat Immunologicals Debt to Equity vs. Net Income Fundamental Analysis

Bharat Immunologicals Biologicals Corp Ltd is rated below average in net income category among related companies. It is number one stock in debt to equity category among related companies .
Net income is the profit of a company for the reporting period which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most watched numbers by money managers as well as individual investors.
Bharat Immunologicals 
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
=
(53.46 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin which measures income as a percentage of sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Bharat Immunologicals 
D/E 
 = 
Total Debt 
Total Equity 
=
0.50 times
High Debt to Equity ratio typically indicates that a firm has been barrowing aggressive to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging barrowing against the capital invested by the owners.

Comparison

Debt to Equity Comparison
Bharat Immunologicals is currently under evaluation in debt to equity category among related companies.
Bharat Immunologicals is currently under evaluation in net income category among related companies.
Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. more
NameBharat Immunologicals Biologicals Corp Ltd
Macroaxis Advice
InstrumentIndia Stock Stocks Directory
ExchangeBombay Stock Exchange
CurrencyINR
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders